Brainstorm Cell Therapeutics
Price & Volume
Stats
See more52W Range | $1.05-$11.89 |
Market Cap | $13M |
Shares Short | 148,229 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.75 |
News
See moreYahoo Finance • last year
DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Yahoo Finance • last year
BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
About
CEO | Mr. Chaim Lebovits |
CFO | Ms. Alla Patlis CPA, M.B.A. |
Address | 1325 Avenue of Americas, New York, NY, United States, 10019 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |
